These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2924921)

  • 1. Mode of binding of E-64-c, a potent thiol protease inhibitor, to papain as determined by X-ray crystal analysis of the complex.
    Matsumoto K; Yamamoto D; Ohishi H; Tomoo K; Ishida T; Inoue M; Sadatome T; Kitamura K; Mizuno H
    FEBS Lett; 1989 Mar; 245(1-2):177-80. PubMed ID: 2924921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined x-ray structure of papain.E-64-c complex at 2.1-A resolution.
    Yamamoto D; Matsumoto K; Ohishi H; Ishida T; Inoue M; Kitamura K; Mizuno H
    J Biol Chem; 1991 Aug; 266(22):14771-7. PubMed ID: 1860874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a papain-E-64 complex.
    Varughese KI; Ahmed FR; Carey PR; Hasnain S; Huber CP; Storer AC
    Biochemistry; 1989 Feb; 28(3):1330-2. PubMed ID: 2713367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation of papain-E-64 (N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl]agmatine) complex.
    Yamamoto D; Ohishi H; Ishida T; Inoue M; Sumiya S; Kitamura K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2339-43. PubMed ID: 2285970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A resolution: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors.
    Yamamoto A; Tomoo K; Doi M; Ohishi H; Inoue M; Ishida T; Yamamoto D; Tsuboi S; Okamoto H; Okada Y
    Biochemistry; 1992 Nov; 31(46):11305-9. PubMed ID: 1445868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the binding modes of a substrate and inhibitor to papain as observed in complex crystal structures.
    Yamamoto D; Ishida T; Inoue M
    Biochem Biophys Res Commun; 1990 Sep; 171(2):711-6. PubMed ID: 2403359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of papain-E64-c complex. Binding diversity of E64-c to papain S2 and S3 subsites.
    Kim MJ; Yamamoto D; Matsumoto K; Inoue M; Ishida T; Mizuno H; Sumiya S; Kitamura K
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):797-803. PubMed ID: 1445241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two polymorphs of a covalent complex between papain and a diazomethylketone inhibitor.
    Janowski R; Kozak M; Jankowska E; Grzonka Z; Jaskólski M
    J Pept Res; 2004 Oct; 64(4):141-50. PubMed ID: 15357669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray crystallographic structure of a papain-leupeptin complex.
    Schröder E; Phillips C; Garman E; Harlos K; Crawford C
    FEBS Lett; 1993 Jan; 315(1):38-42. PubMed ID: 8416808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of chloromethyl ketone substrate analogues to crystalline papain.
    Drenth J; Kalk KH; Swen HM
    Biochemistry; 1976 Aug; 15(17):3731-8. PubMed ID: 952885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and molecular conformation of E-64, a cysteine protease inhibitor.
    Yamamoto D; Matsumoto K; Ishida T; Inoue M; Sumiya S; Kitamura K
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2577-81. PubMed ID: 2611926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an actinidin-E-64 complex.
    Varughese KI; Su Y; Cromwell D; Hasnain S; Xuong NH
    Biochemistry; 1992 Jun; 31(22):5172-6. PubMed ID: 1606141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function relationships in the cysteine proteinases actinidin, papain and papaya proteinase omega. Three-dimensional structure of papaya proteinase omega deduced by knowledge-based modelling and active-centre characteristics determined by two-hydronic-state reactivity probe kinetics and kinetics of catalysis.
    Topham CM; Salih E; Frazao C; Kowlessur D; Overington JP; Thomas M; Brocklehurst SM; Patel M; Thomas EW; Brocklehurst K
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):79-92. PubMed ID: 1741760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex.
    Yamamoto A; Hara T; Tomoo K; Ishida T; Fujii T; Hata Y; Murata M; Kitamura K
    J Biochem; 1997 May; 121(5):974-7. PubMed ID: 9192742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of two engineered thiol trypsins.
    McGrath ME; Wilke ME; Higaki JN; Craik CS; Fletterick RJ
    Biochemistry; 1989 Nov; 28(24):9264-70. PubMed ID: 2611228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A re-appraisal of the structural basis of stereochemical recognition in papain. Insensitivity of binding-site-catalytic-site signalling to P2-chirality in a time-dependent inhibition.
    Templeton W; Kowlessur D; Thomas EW; Topham CM; Brocklehurst K
    Biochem J; 1990 Mar; 266(3):645-51. PubMed ID: 2327953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of Val-157 hydrophobic interaction for papain inhibitory activity of an epoxysuccinyl amino acid derivative. A structure-activity relationship based on the crystal structure of the papain-E-64-c complex.
    Yamamoto D; Matsumoto K; Ohishi H; Ishida T; Inoue M; Kitamura K; Hanada K
    FEBS Lett; 1990 Apr; 263(1):134-6. PubMed ID: 2332044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex.
    Yamamoto A; Tomoo K; Hara T; Murata M; Kitamura K; Ishida T
    J Biochem; 2000 Apr; 127(4):635-43. PubMed ID: 10739956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that binding to the s2-subsite of papain may be coupled with catalytically relevant structural change involving the cysteine-25-histidine-159 diad. Kinetics of the reaction of papain with a two-protonic-state reactivity probe containing a hydrophobic side chain.
    Brocklehurst K; Malthouse JP; Shipton M
    Biochem J; 1979 Nov; 183(2):223-31. PubMed ID: 43129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.
    LaLonde JM; Zhao B; Smith WW; Janson CA; DesJarlais RL; Tomaszek TA; Carr TJ; Thompson SK; Oh HJ; Yamashita DS; Veber DF; Abdel-Meguid SS
    J Med Chem; 1998 Nov; 41(23):4567-76. PubMed ID: 9804696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.